Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.

ABSTRACT:

Background

Inclusion of productivity losses and gains in cost-effectiveness analyses for drugs is recommended by pharmacoeconomic guidelines in some countries and is considered optional in others. Often guidelines recommend analysis based on the payer perspective, but suggest that a supplemental analysis based on the societal perspective may be submitted that includes productivity losses/gains. However, there is no universally recognized framework for the approach to including productivity losses and gains in pharmacoeconomic analyses.

Objectives

This study aimed to systematically review literature on cost-effectiveness analyses of drug interventions that included costs associated with productivity losses/gains and to summarize the types cost elements included and cost calcu

SUBMITTER: Yuasa A 

PROVIDER: S-EPMC7790765 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature